BCRX: financial statements from SEC

Income statement

Metric	31/12/2025	31/12/2024
Revenue	875M	451M
Cost of revenue	19M	12M
Research and development	166M	175M
Selling, general and administrative	349M	266M
Operating expenses	534M	453M
Operating income	341M	−3M
Pre-tax income	267M	−87M
Income tax	4M	2M
Net income	264M	−89M
Earnings per share	1.26	−0.43
Earnings per share, diluted	1.21	−0.43
Weighted average shares	210M	207M
Weighted average shares, diluted	219M	207M

Metric	31/03/2026	31/12/2025	30/09/2025	30/06/2025	31/03/2025	31/12/2024	30/09/2024	30/06/2024
Cash and equivalents	172M	90M	84M	88M	105M	105M	97M	78M
Short-term investments	67M	185M	129M	172M	190M	216M	—	—
Receivables	109M	107M	91M	91M	93M	79M	72M	69M
Inventory	6M	5M	5M	5M	7M	8M	8M	4M
Current assets	374M	404M	356M	398M	410M	422M	427M	363M
Property, plant and equipment	9M	9M	8M	8M	8M	8M	7M	8M
Total assets	465M	514M	446M	457M	480M	490M	491M	472M
Current liabilities	195M	196M	190M	177M	140M	160M	154M	129M
Long-term debt	395M	0	194M	243M	315M	315M	314M	314M
Total liabilities	1.02B	633M	834M	879M	932M	966M	960M	—
Equity	−554M	−119M	−388M	−422M	−452M	−476M	−469M	−476M
Shares outstanding	254M	213M	211M	210M	209M	209M	207M	207M
Shares issued	254M	213M	211M	210M	209M	209M	207M	207M

Metric	31/12/2025	31/12/2024
Operating cash flow	347M	−52M
Depreciation and amortisation	1M	1M
Share-based compensation	85M	65M
Capital expenditure	2M	1M
Investing cash flow	−14M	53M
Financing cash flow	−350M	−6M